ReviewNeuropsychology review2026
Substance-induced Psychotic Disorders Cause Convergent Cognitive Impairment to Schizophrenia Spectrum Disorders: A meta-analysis of Comparative Studies.
Review in Neuropsychology review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This is a meta-analysis of studies that compare cognitive functioning between schizophrenia spectrum disorders and substance-induced psychotic disorder. PubMed, Web of Science and Google Scholar databases were systematically searched. Studies meeting the inclusion criteria were analysed. The risk of bias was assessed by QUADAS-2. Studies were pooled using a random effect model, and reported means and standard deviation (SD) were converted to Hedges’g which corrects for positive bias in Cohen’s d. Eighteen studies with 1092 patients were included in the analysis. The random effects overall meta-analysis model resulted in no overall effect. The meta-analysis for each cognitive domain showed a subtle but significant difference in executive functions, favouring substance-induced psychotic disorder. The equivalence of the groups was demonstrated by comparable performance in memory, attention, psychomotor speed, and intellectual functioning. This meta-analysis revealed that the cognitive impairment in patients with schizophrenia and substance-induced psychotic disorders groups may be quite similar. This finding indicates that the harmful effect of substance use, which leads to psychosis, may cause as severe impairment of cognitive functions as schizophrenia. Our findings also suggest that differences in executive functioning may differentiate schizophrenia from substance-induced psychotic disorder.
Indexed as
Identifiers
41941039What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.